Invega Sustenna Suspension For Injection 117Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Invega Sustenna: Suspension for injection (117mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Invega Sus 117mg/0.75ml ER Inj

What is this Medicine?

PALIPERIDONE (pal ee PER i done) injection is either given as a once-monthly injection (Invega Sustenna) for the treatment of schizophrenia and schizoaffective disorder or as an injection every 3 months (Invega Trinza) for the treatment of schizophrenia.

CVS Pharmacy Patient Statistics for Invega Sustenna: Suspension for injection(117mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Invega Sustenna 117mg/0.75ml Extended-Release Suspension for Injection

NDC: 504580562
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Schizophrenia, Schizoaffective Disorder

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Invega Sustenna 117mg/0.75ml Extended-Release Suspension for Injection

Reported Side Effects for Invega Sustenna 117mg/0.75ml Extended-Release Suspension for Injection

Vomiting Incidence:
<11.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Irregular Periods Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Fats Incidence:
<11.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<11.0%*
Severity: MODERATE
Onset: DELAYED
Bundle-branch Block Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Stomach Pain Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Nightmares Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Tiredness Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
<10.0%*
Severity: MILD
Onset: RAPID
Gynecomastia Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Galactorrhea Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Dystonic Reaction Incidence:
<14.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
<4.0%*
Severity: MILD
Onset: DELAYED
Pseudoparkinsonism Incidence:
<14.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
<11.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<14.0%*
Severity: MODERATE
Onset: RAPID
Heart Block Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<9.0%*
Severity: MILD
Onset: DELAYED
No Menstrual Periods Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
<12.0%*
Severity: MILD
Onset: EARLY
Extra Saliva Production Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Sore Throat Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Postural Low Blood Pressure Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
0.8%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Tooth Pain Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Dyskinesia Incidence:
1.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Dysarthria Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
1.0-26.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
High Triglycerides Incidence:
1.3-13.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.0-8.0%*
Severity: MILD
Onset: EARLY
Causing To Be Hungry Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Hyperkinesis Incidence:
3.0-17.0%*
Severity: MILD
Onset: DELAYED
Restlessness Incidence:
3.0-17.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
3.0-19.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
4.0-15.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
4.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Distressed Incidence:
4.0-10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0-6.0%*
Severity: MILD
Onset: EARLY
High Prolactin Level Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Invega Sustenna

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5